FGF21 and stage 5 chronic kidney disease: An intriguing prospective cohort study in Singapore, involving 1700 Asian people with T2DM and a mean follow-up of 6.3 years, found that in women with T2DM, plasma FGF21 levels independently predicted the risk of progression to end-stage renal disease.